Glomeratose A

CAS No. 202471-84-9

Glomeratose A( —— )

Catalog No. M20409 CAS No. 202471-84-9

Glomeratose A is a lactate dehydrogenase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 255 In Stock
10MG 380 In Stock
25MG 619 In Stock
50MG 861 In Stock
100MG 1152 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Glomeratose A
  • Note
    Research use only, not for human use.
  • Brief Description
    Glomeratose A is a lactate dehydrogenase inhibitor.
  • Description
    Glomeratose A is a lactate dehydrogenase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    lactate dehydrogenase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    202471-84-9
  • Formula Weight
    562.5
  • Molecular Formula
    C24H34O15
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (177.77 mM)
  • SMILES
    COc1cc(cc(OC)c1OC)\C=C\C(=O)O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Li S Liu S Liu Z et al. Bioactivity screening extraction and separation of lactate dehydrogenase inhibitors from\r?Polygala tenuifolia\r Willd. based on a hyphenated strategy[J]. Journal of Separation Science 2017 40(6):1385-1395.
molnova catalog
related products
  • IDH2R140Q-IN-2

    IDH2R140Q-IN-2 is an orally active and potent IDH2R140Q inhibitor with an IC50 of 29 nM.IDH2R140Q-IN-2 possesses potential antitumour activity, reducing D2HG production in TF-1 cell lines carrying the IDH2R140Q mutation (IC50 of 10 nM) and inhibiting tumour tissue D2HG levels.

  • Epostane

    Epostane acts as an antiprogestogen and terminates pregnancy by inhibiting 3β-hydroxysteroid dehydrogenase and preventing the biosynthesis of progesterone and pregnenolone.

  • Trilostane

    Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome.